بدائل البحث:
decrease » increase (توسيع البحث)
يعرض 1 - 20 نتائج من 57 نتيجة بحث عن '(( significant positive breast ) OR ( significant burden decrease ))', وقت الاستعلام: 0.11s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome حسب Faruk Skenderi (6616190)

    منشور في 2022
    "…HER2+/APO tumors tend to have a less aggressive phenotype and a more favorable outcome despite a markedly lower ER/PR positivity.</p><h2>Other Information</h2> <p> Published in: Breast Cancer Research and Treatment<br> License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1007/s10549-022-06578-4" target="_blank">http://dx.doi.org/10.1007/s10549-022-06578-4</a></p>…"
  4. 4

    Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positiv... حسب Dimassi, Hani

    منشور في 2009
    "…The status of the axillary lymph nodes in nonmetastatic lymph node-positive breast cancer (BC) patients remains the single most important determinant of overall survival (OS). …"
    احصل على النص الكامل
    احصل على النص الكامل
    article
  5. 5

    Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer حسب Rasha M. Sareyeldin (18131371)

    منشور في 2019
    "…Despite the anti-HER2 and cytotoxic chemotherapy, HER2 subtype is an aggressive disease with significant mortality. Recent advances in molecular biology techniques, including gene expression profiling, proteomics, and microRNA analysis, have been extensively used to explore the underlying mechanisms behind human breast carcinogenesis and metastasis including HER2-positive breast cancer, paving the way for developing new targeted therapies. …"
  6. 6

    Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways حسب Hadeel Kheraldine (14231609)

    منشور في 2024
    "…</p><h3>Conclusion</h3><p dir="ltr">Our findings implicate that a combination of DA and BMS-202 could have a significant impact on the management of HER2-positive breast cancer.…"
  7. 7

    Trends of the Dementia Burden in South Asia: An Analysis of 2021 Global Burden of Disease Study حسب Shubham Chauhan (21334742)

    منشور في 2025
    "…</p><h3>Results</h3><p dir="ltr">A slight decrease in incidence rates from 80.57 to 79 per 100,000 was observed, alongside a significant increase in mortality rates from 14.11 to 17.2 per 100,000. …"
  8. 8

    Substantial cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive human breast cancer via JNK and ERK1/ERK2 signalling pathways حسب Hadeel Kheraldine (14231609)

    منشور في 2021
    "…<p>HER2-positive breast cancer is one of its most challenging subtypes, forming around 15–25% of the total cases. …"
  9. 9

    Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study حسب Rajesh, Sharma

    منشور في 2024
    "…Tracheal, bronchus, and lung cancer (both sexes), breast cancer (among females), colon and rectum cancer (both sexes), stomach cancer (both sexes) and prostate cancer (among males) were among top-5 cancers in most Asian countries in terms of ASIR and ASMR in 2019 and cancers of liver, stomach, hodgkin lymphoma and esophageal cancer posted the most significant decreases in age-standardized rates between 1990 and 2019. …"
    احصل على النص الكامل
    احصل على النص الكامل
    احصل على النص الكامل
    article
  10. 10
  11. 11

    Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of... حسب Saeid Safiri (3713035)

    منشور في 2021
    "…Bladder cancer accounted for 4.39 million (4.09 to 4.70) DALYs in 2019, and the age-standardised DALY rate decreased significantly by 18.6% (11.2 to 24.3) during the period 1990–2019. …"
  12. 12

    Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis... حسب Marissa B Reitsma (8674341)

    منشور في 2021
    "…Although prevalence of smoking had decreased significantly since 1990 among both males (27·5% [26·5–28·5] reduction) and females (37·7% [35·4–39·9] reduction) aged 15 years and older, population growth has led to a significant increase in the total number of smokers from 0·99 billion (0·98–1·00) in 1990. …"
  13. 13
  14. 14
  15. 15

    Discrimination of breast cancer from benign tumours using Raman spectroscopy حسب Fiona M. Lyng (2189614)

    منشور في 2019
    "…Breast cancer is diagnosed by histopathological examination of breast biopsy material but this is subjective and relies on morphological changes in the tissue. …"
  16. 16
  17. 17

    Assessment of treatment burden and its impact on quality of life in dialysis-dependent and pre-dialysis chronic kidney disease patients حسب Asmaa Al-mansouri (16931739)

    منشور في 2021
    "…<h3>Background</h3><p dir="ltr">The management of chronic kidney disease (CKD) and its complications places a significant burden on patients, resulting in impairment of their health-related quality of life (HR-QOL). …"
  18. 18

    Correction: Discrimination of breast cancer from benign tumours using Raman spectroscopy حسب Fiona M. Lyng (2189614)

    منشور في 2019
    "…<p dir="ltr">Correction to: Discrimination of breast cancer from benign tumours using Raman spectroscopy. …"
  19. 19

    Diagnostic test accuracy of AI-assisted mammography for breast imaging: a narrative review حسب Daksh Dave (17949239)

    منشور في 2025
    "…The motivation for this research lies in addressing the need for enhanced diagnostic tools in breast cancer screening, where early detection can significantly impact patient outcomes. …"
  20. 20

    Rhus coriaria L. (Sumac) Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma حسب Peter Kubatka (11008854)

    منشور في 2020
    "…In conclusion, sumac demonstrated significant oncostatic activities in rodent models of breast carcinoma that were validated by mechanistic studies in vivo and in vitro.…"